Navigation Links
FDA Warns Against Sale of Sports Supplements in U.S.
Date:4/15/2013

MONDAY, April 15 (HealthDay News) -- Dietary supplements that contain a stimulant called dimethylamylamine (DMAA) pose numerous health risks and are no longer allowed to be sold in the United States, the U.S. Food and Drug Administration has warned.

DMAA -- which is most often used in supplements promising weight loss, muscle-building and improvement of athletic performance -- can increase blood pressure and may lead to cardiovascular problems such as heart attack, shortness of breath and tightening of the chest. The stimulant may be particularly dangerous when used with caffeine, according to the FDA.

The agency has received 60 reports of illnesses and deaths associated with supplements containing DMAA. The incidents included heart problems and nervous system or psychiatric disorders.

However, a report in itself doesn't prove that a product caused a health problem, an agency news release noted.

The FDA sent warning letters to companies that use DMAA in dietary supplements. All but one of the companies have agreed to stop using the ingredient in their products. One company, USPLabs, has not complied. It responded to the warning letter by submitting published studies that the company said challenge the FDA's concerns.

However, the FDA said the studies did not have sufficient information to defend the use of DMAA in dietary supplements. The government agency is finalizing a formal response to USPLabs, according to Daniel Fabricant, director of FDA's division of dietary supplement programs.

As the FDA continues its efforts to get the stimulant off the market, it urges consumers to check labels and avoid any dietary supplements containing DMAA. Consumers need to be aware that the ingredient can be referred to by 10 possible names. These are listed on the FDA's DMAA web page.

More information

The U.S. Food and Drug Administration has more about DMAA.

-- Robert Preidt

SOURCE: U.S. Food and Drug Administration, news release, April 11, 2013


'/>"/>
Copyright©2012 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. DrugRisks Stryker Recall Update: Company Warns Investors as Patients Alleging Injury Ask to Send Lawsuits to Federal Court
2. American Association of Poison Control Centers Warns That Children Act Fast … and So Do Poisons
3. Know Whats in Your Childs Medications, FDA Warns
4. Facebook Likes Leave a Personal Trail, Study Warns
5. Tattoos Can Pose Health Hazards, Doctor Warns
6. Eating Out Can Hurt Heart Health, Expert Warns
7. Law Firm Warns Patients Who Have Received Alleged Defective Smith & Nephew Hip and Knee Replacement Systems
8. Dont Overlook Eating Issues Tied to Autism, Study Warns
9. Beware Fake Flu Treatments, FDA Warns
10. Winter Holds Many Hazards for Seniors, Expert Warns
11. Health Canada Warns on Interaction of Prilosec with Methotrexate: AttorneyOne Informs
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
FDA Warns Against Sale of Sports Supplements in U.S.
(Date:2/23/2017)... ... ... Thomas Vas-Don suffered from severe injury due to an ... successfully recover. In “ Origin & Insertion Charts for Massage Therapists ” (published by ... massage, anatomy , trigger points and referral pain patterns . , In ...
(Date:2/22/2017)... ... February 22, 2017 , ... Stem cell ... years. The technology is so cutting edge, in fact, the U.S. Food and ... cell procedures. However, successful patient outcomes in certain clinical stem cell procedures have ...
(Date:2/22/2017)... CRANBURY, N.J. (PRWEB) , ... February 22, 2017 ... ... than a one-size-fits-all approach, leads to fewer trips the emergency room, fewer hospital ... in The American Journal of Managed Care® (AJMC®) finds. The study can be ...
(Date:2/22/2017)... ... ... Sideline Products participated in the World Horse Expo held in Timonium, MD ... production crew. Tom Seay’s program “Best of America by Horseback” is broadcasted on ... be featured on April 6, 2017. After the broadcast, the clip will be posted ...
(Date:2/22/2017)... ... February 22, 2017 , ... The Centers ... to help small practices in Delaware, New Jersey, Pennsylvania and West Virginia prepare ... Access and CHIP Reauthorization Act of 2015 (MACRA). , This technical assistance, ...
Breaking Medicine News(10 mins):
(Date:2/23/2017)... Wash. and VANCOUVER, British Columbia ... (NASDAQ: OGXI ) today announced its year ... In January 2017, OncoGenex, and Achieve Life ... that they have entered into a definitive merger agreement ... transaction. Upon completion of the proposed merger, Achieve,s stockholders ...
(Date:2/23/2017)... England and DEERFIELD, Ill. ... U.S.A. , Inc., a wholly-owned subsidiary of ... a joint venture between Cambridge Cognition Holdings PLC and ... use of a specially designed app on an Apple ... patients with Major Depressive Disorder (MDD). Depression ...
(Date:2/22/2017)... Feb. 22, 2017 General Report Contents ... Value & Growth Trends - Market Drivers & ... for each chapter segment - Section on recent ... report: https://www.reportbuyer.com/product/4665946/ This market ... methods: articulated arm lasers, fiber-delivered lasers and direct ...
Breaking Medicine Technology: